Zurich Cantonal Bank’s RxSight RXST Stock Holding History

Zurich Cantonal Bank’s Portfolio RXST Stock Details RXST Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$34	Hold	7	–	–	﹤0.01%	2537
2026 Q1	$43	Buy	+7	New	+$58	﹤0.01%	2529
2025 Q4	–	Sell	-7	Closed	-$70	–	3348
2025 Q3	$63	Sell	7 -5,833	-100%	-$51.2K	﹤0.01%	2541
2025 Q2	$75.9K	Hold	5,840	–	–	﹤0.01%	2409
2025 Q1	$147K	Hold	5,840	–	–	﹤0.01%	2247
2024 Q4	$201K	Sell	5,840 -3,336	-36%	-$150K	﹤0.01%	2149
2024 Q3	$454K	Sell	9,176 -2,190	-19%	-$112K	﹤0.01%	1622
2024 Q2	$684K	Buy	11,366 +8,058	+244%	+$460K	﹤0.01%	1272
2024 Q1	$171K	Hold	3,308	–	–	﹤0.01%	2132
2023 Q4	$133K	Sell	3,308 -910	-22%	-$26.7K	﹤0.01%	2307
2023 Q3	$118K	Hold	4,218	–	–	﹤0.01%	2283
2023 Q2	$121K	Buy	+4,218	New	+$93.8K	﹤0.01%	2246

Other funds holding RXST

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Millennium Management New York $276B AUM 44.8% 1-Year Est. Return

NSGL

No Street GP LP San Francisco, California $1.66B AUM 39.91% 1-Year Est. Return

Nomura Holdings Tokyo, Japan $85.4B AUM 91.09% 1-Year Est. Return

D.E. Shaw & Co New York $210B AUM 57.28% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

AQR Capital Management Greenwich, Connecticut $287B AUM 42.33% 1-Year Est. Return

Acadian Asset Management Boston, Massachusetts $84.2B AUM 55.88% 1-Year Est. Return

Federated Hermes Pittsburgh, Pennsylvania $69.6B AUM 42.52% 1-Year Est. Return

Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return

Zurich Cantonal Bank's RXST Position: Q2 2026 in Review

Zurich Cantonal Bank held its RxSight (RXST) position steady in Q2 2026 at 7 shares worth $34. The position accounts for ﹤0.01% of the portfolio, ranked #2537.

Zurich Cantonal Bank first reported a position in RXST in Q2 2023 and has held it in 12 quarters since. The position peaked at $684K in Q2 2024. 151 funds tracked by Wall St. Rank hold RXST as of Q2 2026.

Zurich Cantonal Bank held 7 shares of RxSight worth $34 as of Q2 2026.
Zurich Cantonal Bank left its RxSight share count unchanged in Q2 2026.
RxSight made up ﹤0.01% of Zurich Cantonal Bank's portfolio in Q2 2026, its #2537 holding.
Zurich Cantonal Bank first reported a position in RxSight in Q2 2023 and has held it in 12 quarters since.
Zurich Cantonal Bank's RxSight position peaked at $684K in Q2 2024.
151 funds tracked by Wall St. Rank held RxSight as of Q2 2026.

Based on Zurich Cantonal Bank's 13F filing for Q2 2026, filed 12 Aug 2026.